| Year |
Citation |
Score |
| 2020 |
Nadel CM, Ran X, Gestwicki JE. Luminescence Complementation Assay for Measurement of Binding to Protein C-Termini in Live Cells. Analytical Biochemistry. 113947. PMID 32918866 DOI: 10.1016/J.Ab.2020.113947 |
0.399 |
|
| 2018 |
Zhao Y, Zhou B, Bai L, Liu L, Yang CY, Meagher JL, Stuckey JA, McEachern D, Przybranowski S, Wang M, Ran X, Aguilar A, Hu Y, Kampf JW, Li X, et al. Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. Journal of Medicinal Chemistry. PMID 30015487 DOI: 10.1021/Acs.Jmedchem.8B00483 |
0.564 |
|
| 2018 |
Ran X, Gestwicki JE. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. Current Opinion in Chemical Biology. 44: 75-86. PMID 29908451 DOI: 10.1016/J.Cbpa.2018.06.004 |
0.504 |
|
| 2018 |
Ran X, Burchfiel ET, Dong B, Rettko NJ, Dunyak BM, Shao H, Thiele DJ, Gestwicki JE. Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1). Bioorganic & Medicinal Chemistry. PMID 29661622 DOI: 10.1016/J.Bmc.2018.04.018 |
0.502 |
|
| 2018 |
Taylor IR, Dunyak BM, Komiyama T, Shao H, Ran X, Assimon VA, Kalyanaraman C, Rauch JN, Jacobson MP, Zuiderweg ERP, Gestwicki JE. High Throughput Screen for Inhibitors of Protein-Protein Interactions in a Reconstituted Heat Shock Protein 70 (Hsp70) Complex. The Journal of Biological Chemistry. PMID 29414793 DOI: 10.1074/Jbc.Ra117.001575 |
0.429 |
|
| 2017 |
Karatas H, Li Y, Liu L, Ji J, Lee S, Chen Y, Yang J, Huang L, Bernard D, Xu J, Townsend EC, Cao F, Ran X, Li X, Wen B, et al. Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)-Mixed Lineage Leukemia (MLL) Protein-Protein Interaction. Journal of Medicinal Chemistry. PMID 28603984 DOI: 10.1021/Acs.Jmedchem.6B01796 |
0.632 |
|
| 2017 |
Zhao Y, Bai L, Liu L, McEachern D, Stuckey JA, Meagher JL, Yang CY, Ran X, Zhou B, Hu Y, Li X, Wen B, Zhao T, Li S, Sun D, et al. Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. Journal of Medicinal Chemistry. PMID 28463487 DOI: 10.1021/Acs.Jmedchem.7B00193 |
0.568 |
|
| 2015 |
Ran X, Liu L, Yang C, Lu J, Chen Y, Lei M, Wang S. Design of High-affinity Stapled Peptides to Target the Repressor Activator Protein 1 (RAP1)/Telomeric Repeat-binding Factor 2 (TRF2) Protein-Protein Interaction in the Shelterin Complex. Journal of Medicinal Chemistry. PMID 26673461 DOI: 10.1021/Acs.Jmedchem.5B01465 |
0.635 |
|
| 2015 |
Ran X, Zhao Y, Liu L, Bai L, Yang CY, Zhou B, Meagher JL, Chinnaswamy K, Stuckey JA, Wang S. Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors. Journal of Medicinal Chemistry. 58: 4927-39. PMID 26080064 DOI: 10.1021/Acs.Jmedchem.5B00613 |
0.589 |
|
| 2013 |
Kurokawa M, Kim J, Geradts J, Matsuura K, Liu L, Ran X, Xia W, Ribar TJ, Henao R, Dewhirst MW, Kim WJ, Lucas JE, Wang S, Spector NL, Kornbluth S. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53. Science Signaling. 6: ra32. PMID 23652204 DOI: 10.1126/Scisignal.2003741 |
0.448 |
|
| 2012 |
Kawamoto SA, Coleska A, Ran X, Yi H, Yang CY, Wang S. Design of triazole-stapled BCL9 α-helical peptides to target the β-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction. Journal of Medicinal Chemistry. 55: 1137-46. PMID 22196480 DOI: 10.1021/Jm201125D |
0.476 |
|
| Show low-probability matches. |